Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

[Screening for colorectal cancer in Italy, 2010 survey].

Zorzi M, Fedato C, Grazzini G, Sassoli de' Bianchi P, Naldoni C, Pendenza M, Sassatelli R, Senore C, Visioli CB, Zappa M.

Epidemiol Prev. 2012 Nov-Dec;36(6 Suppl 1):55-77. Italian.

2.

Screening for colorectal cancer in Italy, 2009 survey.

Zorzi M, Baracco S, Fedato C, Grazzini G, Sassoli De' Bianchi P, Senore C, Visioli CB, Cogo C.

Epidemiol Prev. 2011 Sep-Dec;35(5-6 Suppl 5):55-77. English, Italian.

3.

Screening for colorectal cancer in Italy: 2007 survey.

Zorzi M, Fedato C, Naldoni C, Sassatelli R, Sassoli De' Bianchi P, Senore C, Visioli CB, Cogo C.

Epidemiol Prev. 2009 May-Jun;33(3 Suppl 2):57-74.

4.

Screening for colorectal cancer in Italy: 2008 survey.

Zorzi M, Baracco S, Fedato C, Grazzini G, Naldoni C, Sassoli dé Bianchi P, Senore C, Visioli CB, Cogo C.

Epidemiol Prev. 2010 Sep-Dec;34(5-6 Suppl 4):53-72.

5.

Screening for colorectal cancer in Italy: 2011-2012 survey.

Zorzi M, Da Re F, Mantellini P, Naldoni C, Sassoli De'Bianchi P, Senore C, Turrin A, Visioli CB, Zappa M; Italian colorectal cancer screening survey group.

Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):93-107.

6.

Screening for colorectal cancer in Italy: 2006 survey.

Zorzi M, Falcini F, Fedato C, Grazzini G, de' Bianchi PS, Senore C, Vettorazzi M, Visioli C, Zappa M.

Epidemiol Prev. 2008 Mar-Apr;32(2 Suppl 1):55-68.

7.

Screening for colorectal cancer in Italy: 2005 survey.

Zorzi M, Barca A, Falcini F, Grazzini G, Pizzuti R, Ravaioli A, Sassoli de Bianchi P, Senore C, Sigillito A, Vettorazzi M, Visioli C.

Epidemiol Prev. 2007 Mar-Jun;31(2-3 Suppl 2):49-60.

8.

Screening for colorectal cancer in Italy: 2004 survey.

Zorzi M, Grazzini G, Senore C, Vettorazzi M.

Epidemiol Prev. 2006 Jan-Feb;30(1 Suppl 3):41-50.

9.

Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.

Segnan N, Senore C, Andreoni B, Azzoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, Ederle A, Fantin A, Ferrari A, Fracchia M, Ferrero F, Gasperoni S, Recchia S, Risio M, Rubeca T, Saracco G, Zappa M; SCORE3 Working Group-Italy.

Gastroenterology. 2007 Jun;132(7):2304-12. Epub 2007 Mar 21.

PMID:
17570205
10.

Colorectal cancer screening of immigrants to Italy. Figures from the 2013 National Survey.

Turrin A, Zorzi M, Giorgi Rossi P, Senore C, Campari C, Fedato C, Naldoni C, Anghinoni E, Carrozzi G, Sassoli De' Bianchi P, Zappa M; Italian colorectal cancer screening survey group.

Prev Med. 2015 Dec;81:132-7. doi: 10.1016/j.ypmed.2015.08.016. Epub 2015 Sep 7.

PMID:
26358527
11.

Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).

Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, Fasoli R, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex D, Hassan C, Zappa M; Equipe Working Group.

Gut. 2015 Sep;64(9):1389-96. doi: 10.1136/gutjnl-2014-307954. Epub 2014 Sep 16.

PMID:
25227521
12.

Offering people a choice for colorectal cancer screening.

Senore C, Ederle A, Benazzato L, Arrigoni A, Silvani M, Fantin A, Fracchia M, Armaroli P, Segnan N.

Gut. 2013 May;62(5):735-40. doi: 10.1136/gutjnl-2011-301013. Epub 2012 Mar 22.

PMID:
22442162
13.

Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.

Mansouri D, McMillan DC, Roxburgh CS, Moug SJ, Crighton EM, Horgan PG.

Colorectal Dis. 2013 Nov;15(11):1375-81. doi: 10.1111/codi.12377.

PMID:
23927751
14.

What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences.

Ventura L, Zappa M, Carreras G, Ciatto S, Grazzini G.

Tumori. 2011 Sep-Oct;97(5):547-50. doi: 10.1700/989.10709.

15.

Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting.

Senore C, Ederle A, Fantin A, Andreoni B, Bisanti L, Grazzini G, Zappa M, Ferrero F, Marutti A, Giuliani O, Armaroli P, Segnan N.

J Med Screen. 2011;18(3):128-34. doi: 10.1258/jms.2011.010135.

PMID:
22045821
16.

Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ.

Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089.

PMID:
19671542
17.

Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.

Khalid-de Bakker CA, Jonkers DM, Sanduleanu S, de Bruïne AP, Meijer GA, Janssen JB, van Engeland M, Stockbrügger RW, Masclee AA.

Cancer Prev Res (Phila). 2011 Oct;4(10):1563-71. doi: 10.1158/1940-6207.CAPR-11-0076. Epub 2011 Jul 12.

18.

Mammography screening in Italy: 2005 survey and 2006 preliminary data.

Giorgi D, Giordano L, Ventura L, Frigerio A, Paci E, Zappa M.

Epidemiol Prev. 2008 Mar-Apr;32(2 Suppl 1):7-22.

19.

[Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].

Trevisani L, Cifalà V, Sartori S, Tombesi P, Matarese V, Pezzoli A, Abbasciano V.

Recenti Prog Med. 2009 Feb;100(2):68-72. Italian.

PMID:
19350797
20.

Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).

Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, de Pretis G, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex DK, Zappa M, Hassan C; Equipe Working Group.

Gut. 2017 Jul;66(7):1233-1240. doi: 10.1136/gutjnl-2015-310587. Epub 2016 Feb 19.

PMID:
26896459

Supplemental Content

Support Center